Advanced in Kaposi Sarcoma

Wadzanai P. Samaneka

Harare, HA, ZW 
Advanced in Kaposi Sarcoma
Harare, HA, ZW 
OverviewLocationsClinical Research

Overview

Wadzanai Samaneka practices in Harare, Zimbabwe. Samaneka is rated as an Advanced expert by MediFind in the treatment of Kaposi Sarcoma. Their top areas of expertise are Kaposi Sarcoma, HIV/AIDS, Pulmonary Tuberculosis, and Adult Soft Tissue Sarcoma.

Their clinical research consists of co-authoring 42 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 5 articles in the study of Kaposi Sarcoma.

Locations

Harare, HA, Zimbabwe
Other Locations
Zimbabwe, MV, Zimbabwe
15 Phillips Avenue, Belgravia, HA, Zimbabwe

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or With Rifampin-Containing TB Treatment: The Hakim Study
Observational Cohort to Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of Tenofovir-Lamivudine-Dolutegravir (TLD) for First- or Second-Line ART or With Rifampin-Containing TB Treatment: The Hakim Study
Enrollment Status: Completed
Publish Date: August 21, 2023

42 Total Publications

A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial.
Journal: The Lancet. Infectious diseases
Published: April 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Samaneka's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile